{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:19:46Z","timestamp":1793225986702,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66509-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T09:03:33Z","timestamp":1764147813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Uncovering the immune mechanisms underlying the emergence of immunotherapy-induced pneumonitis in lung cancer patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Xinqing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-4154","authenticated-orcid":false,"given":"Chunjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6810-5712","authenticated-orcid":false,"given":"Jiaxi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0536-9634","authenticated-orcid":false,"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-9099","authenticated-orcid":false,"given":"Qingjun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8943-2956","authenticated-orcid":false,"given":"Shengbao","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5890-8335","authenticated-orcid":false,"given":"Chengzhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"66509_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"66509_CR2","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1001\/jamaoncol.2016.2453","volume":"2","author":"M Nishino","year":"2016","unstructured":"Nishino, M., Giobbie-Hurder, A., Hatabu, H., Ramaiya, N. H. & Hodi, F. S. Incidence of programmed cell death 1 inhibitor-related pneumonitis in patients with advanced cancer: a systematic review and meta-analysis. JAMA Oncol. 2, 1607\u20131616 (2016).","journal-title":"JAMA Oncol."},{"key":"66509_CR3","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","volume":"4","author":"DY Wang","year":"2018","unstructured":"Wang, D. Y. et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 4, 1721\u20131728 (2018).","journal-title":"JAMA Oncol."},{"key":"66509_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","volume":"54","author":"JM Michot","year":"2016","unstructured":"Michot, J. M. et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur. J. Cancer 54, 139\u2013148 (2016).","journal-title":"Eur. J. Cancer"},{"key":"66509_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3389\/fphar.2018.01430","volume":"9","author":"K Ma","year":"2018","unstructured":"Ma, K. et al. The relative risk and incidence of immune checkpoint inhibitors related pneumonitis in patients with advanced cancer: a meta-analysis. Front Pharm. 9, 1430 (2018).","journal-title":"Front Pharm."},{"key":"66509_CR6","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jtho.2021.06.024","volume":"16","author":"J Luo","year":"2021","unstructured":"Luo, J. et al. Beyond steroids: immunosuppressants in steroid-refractory or resistant immune-related adverse events. J. Thorac. Oncol. 16, 1759\u20131764 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"66509_CR7","volume":"82","author":"M Camard","year":"2022","unstructured":"Camard, M. et al. Prevalence and outcome of steroid-resistant\/refractory pneumonitis induced by immune checkpoint inhibitors. Respir. Med Res 82, 100969 (2022).","journal-title":"Respir. Med Res"},{"key":"66509_CR8","doi-asserted-by":"crossref","unstructured":"Balaji, A. et al. Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes. J Immunother. Cancer 9, e001731 (2021).","DOI":"10.1136\/jitc-2020-001731"},{"key":"66509_CR9","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.chest.2018.08.1048","volume":"154","author":"K Suresh","year":"2018","unstructured":"Suresh, K., Naidoo, J., Lin, C. T. & Danoff, S. Immune checkpoint immunotherapy for non-small cell lung cancer: benefits and pulmonary toxicities. Chest 154, 1416\u20131423 (2018).","journal-title":"Chest"},{"key":"66509_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13614-1","volume":"25","author":"R Gao","year":"2025","unstructured":"Gao, R. et al. Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system. BMC Cancer 25, 216 (2025).","journal-title":"BMC Cancer"},{"key":"66509_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3892\/ol.2020.11618","volume":"20","author":"YN Wang","year":"2020","unstructured":"Wang, Y. N. et al. Elevated levels of IL-17A and IL-35 in plasma and bronchoalveolar lavage fluid are associated with checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer. Oncol. Lett. 20, 611\u2013622 (2020).","journal-title":"Oncol. Lett."},{"key":"66509_CR12","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1172\/JCI128654","volume":"129","author":"K Suresh","year":"2019","unstructured":"Suresh, K. et al. The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis. J. Clin. Investig. 129, 4305\u20134315 (2019).","journal-title":"J. Clin. Investig."},{"key":"66509_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590494","volume":"11","author":"ST Kim","year":"2021","unstructured":"Kim, S. T. et al. Distinct immunophenotypes of T cells in bronchoalveolar lavage fluid from leukemia patients with immune checkpoint inhibitors-related pulmonary complications. Front. Immunol. 11, 590494 (2021).","journal-title":"Front. Immunol."},{"key":"66509_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.818492","volume":"12","author":"X Lin","year":"2022","unstructured":"Lin, X. et al. Comprehensive analysis of the immune microenvironment in checkpoint inhibitor pneumonitis. Front. Immunol. 12, 818492 (2022).","journal-title":"Front. Immunol."},{"key":"66509_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100868","volume":"4","author":"S Bukhari","year":"2023","unstructured":"Bukhari, S. et al. Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors. Cell Rep. Med. 4, 100868 (2023).","journal-title":"Cell Rep. Med."},{"key":"66509_CR16","doi-asserted-by":"publisher","first-page":"e005323","DOI":"10.1136\/jitc-2022-005323","volume":"10","author":"A Franken","year":"2022","unstructured":"Franken, A. et al. Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis. J. Immunother. Cancer 10, e005323 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"66509_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"66509_CR18","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3389\/fimmu.2018.03101","volume":"9","author":"B Stankovic","year":"2018","unstructured":"Stankovic, B. et al. Immune cell composition in human non-small cell lung cancer. Front. Immunol. 9, 3101 (2018).","journal-title":"Front. Immunol."},{"key":"66509_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00262-024-03834-y","volume":"73","author":"R Chen","year":"2024","unstructured":"Chen, R. et al. Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis. Cancer Immunol. Immunother. 73, 235 (2024).","journal-title":"Cancer Immunol. Immunother."},{"key":"66509_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100146","volume":"3","author":"R Liu","year":"2024","unstructured":"Liu, R., Li, H. F. & Li, S. PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy. Cell Insight 3, 100146 (2024).","journal-title":"Cell Insight"},{"key":"66509_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"66509_CR22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1053\/j.gastro.2021.06.025","volume":"161","author":"SC Sasson","year":"2021","unstructured":"Sasson, S. C. et al. Interferon-gamma-producing CD8(+) tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor-colitis. Gastroenterology 161, 1229\u20131244.e1229 (2021).","journal-title":"Gastroenterology"},{"key":"66509_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf1329","volume":"384","author":"D Mathew","year":"2024","unstructured":"Mathew, D. et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science 384, eadf1329 (2024).","journal-title":"Science"},{"key":"66509_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","volume":"37","author":"D Masopust","year":"2019","unstructured":"Masopust, D. & Soerens, A. G. Tissue-resident T cells and other resident leukocytes. Annu. Rev. Immunol. 37, 521\u2013546 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"66509_CR25","doi-asserted-by":"crossref","unstructured":"Szabo, P. A., Miron, M., Farber, D. L. Location, location, location: tissue resident memory T cells in mice and humans. Sci Immunol 4, eaas9673 (2019).","DOI":"10.1126\/sciimmunol.aas9673"},{"key":"66509_CR26","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"50","author":"S Crotty","year":"2019","unstructured":"Crotty, S. T follicular helper cell biology: a decade of discovery and diseases. Immunity 50, 1132\u20131148 (2019).","journal-title":"Immunity"},{"key":"66509_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","volume":"40","author":"T Damelang","year":"2019","unstructured":"Damelang, T., Rogerson, S. J., Kent, S. J. & Chung, A. W. Role of IgG3 in infectious diseases. Trends Immunol. 40, 197\u2013211 (2019).","journal-title":"Trends Immunol."},{"key":"66509_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu, H., Lin, L., Zhang, Z., Zhang, H. & Hu, H. Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct. Target Ther. 5, 209 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"66509_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nri1395","volume":"4","author":"J Chaudhuri","year":"2004","unstructured":"Chaudhuri, J. & Alt, F. W. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4, 541\u2013552 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"66509_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"66509_CR31","doi-asserted-by":"publisher","first-page":"230263","DOI":"10.1183\/16000617.0263-2023","volume":"33","author":"L Pervizaj-Oruqaj","year":"2024","unstructured":"Pervizaj-Oruqaj, L., Ferrero, M. R., Matt, U. & Herold, S. The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis. Eur. Respir. Rev. J. Eur. Respir. Soc. 33, 230263 (2024).","journal-title":"Eur. Respir. Rev. J. Eur. Respir. Soc."},{"key":"66509_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e723 (2021).","journal-title":"Cell"},{"key":"66509_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723\u2013737 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"66509_CR34","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","volume":"185","author":"R Nalio Ramos","year":"2022","unstructured":"Nalio Ramos, R. et al. Tissue-resident FOLR2(+) macrophages associate with CD8(+) T cell infiltration in human breast cancer. Cell 185, 1189\u20131207.e1125 (2022).","journal-title":"Cell"},{"key":"66509_CR35","doi-asserted-by":"publisher","first-page":"22246","DOI":"10.1073\/pnas.1908079116","volume":"116","author":"SA Tahir","year":"2019","unstructured":"Tahir, S. A. et al. Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities. Proc. Natl. Acad. Sci. USA 116, 22246\u201322251 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66509_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cell.2020.06.001","volume":"182","author":"AM Luoma","year":"2020","unstructured":"Luoma, A. M. et al. Molecular pathways of colon inflammation induced by cancer immunotherapy. Cell 182, 655\u2013671.e622 (2020).","journal-title":"Cell"},{"key":"66509_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41420-022-00998-3","volume":"8","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. Cell pyroptosis in health and inflammatory diseases. Cell Death Discov. 8, 191 (2022).","journal-title":"Cell Death Discov."},{"key":"66509_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10097-2","volume":"22","author":"G Fang","year":"2022","unstructured":"Fang, G. et al. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma. BMC Cancer 22, 999 (2022).","journal-title":"BMC Cancer"},{"key":"66509_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44669-y","volume":"15","author":"F Ma","year":"2024","unstructured":"Ma, F. et al. Gasdermin E dictates inflammatory responses by controlling the mode of neutrophil death. Nat. Commun. 15, 386 (2024).","journal-title":"Nat. Commun."},{"key":"66509_CR40","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1038\/emboj.2010.256","volume":"29","author":"M Ren","year":"2010","unstructured":"Ren, M. et al. Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. Embo J. 29, 3952\u20133966 (2010).","journal-title":"Embo J."},{"key":"66509_CR41","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","volume":"29","author":"L Sikkema","year":"2023","unstructured":"Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med 29, 1563\u20131577 (2023).","journal-title":"Nat. Med"},{"key":"66509_CR42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","volume":"587","author":"KJ Travaglini","year":"2020","unstructured":"Travaglini, K. J. et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature 587, 619\u2013625 (2020).","journal-title":"Nature"},{"key":"66509_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/path.5971","volume":"257","author":"G Carraro","year":"2022","unstructured":"Carraro, G. & Stripp, B. R. Insights gained in the pathology of lung disease through single-cell transcriptomics. J. Pathol. 257, 494\u2013500 (2022).","journal-title":"J. Pathol."},{"key":"66509_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/SHK.0b013e3181fddd82","volume":"35","author":"LE Sousse","year":"2011","unstructured":"Sousse, L. E. et al. Acute lung injury-induced collagen deposition is associated with elevated asymmetric dimethylarginine and arginase activity. Shock 35, 282\u2013288 (2011).","journal-title":"Shock"},{"key":"66509_CR45","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.immuni.2021.04.001","volume":"54","author":"B Zhu","year":"2021","unstructured":"Zhu, B. et al. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity 54, 1200\u20131218.e1209 (2021).","journal-title":"Immunity"},{"key":"66509_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142577","volume":"6","author":"G Kashgari","year":"2021","unstructured":"Kashgari, G. et al. GRHL3 activates FSCN1 to relax cell-cell adhesions between migrating keratinocytes during wound reepithelialization. JCI Insight 6, e142577 (2021).","journal-title":"JCI Insight"},{"key":"66509_CR47","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jtho.2021.05.017","volume":"16","author":"C Pozzessere","year":"2021","unstructured":"Pozzessere, C. et al. Imaging features of pulmonary immune-related adverse events. J. Thorac. Oncol. 16, 1449\u20131460 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"66509_CR48","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1097\/PAS.0000000000001298","volume":"43","author":"BT Larsen","year":"2019","unstructured":"Larsen, B. T. et al. Clinical and histopathologic features of immune checkpoint inhibitor-related pneumonitis. Am. J. Surg. Pathol. 43, 1331\u20131340 (2019).","journal-title":"Am. J. Surg. Pathol."},{"key":"66509_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","volume":"40","author":"NS Patil","year":"2022","unstructured":"Patil, N. S. et al. Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer. Cancer Cell 40, 289\u2013300.e284 (2022).","journal-title":"Cancer Cell"},{"key":"66509_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.698832","volume":"11","author":"X Lin","year":"2021","unstructured":"Lin, X. et al. Peripheral blood biomarkers for early diagnosis, severity, and prognosis of checkpoint inhibitor-related pneumonitis in patients with lung cancer. Front. Oncol. 11, 698832 (2021).","journal-title":"Front. Oncol."},{"key":"66509_CR51","doi-asserted-by":"publisher","first-page":"e010114","DOI":"10.1136\/jitc-2024-010114","volume":"12","author":"R Matsukane","year":"2024","unstructured":"Matsukane, R. et al. Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis. J. Immunother. Cancer 12, e010114 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"66509_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2017.09.015","volume":"68","author":"LM Wang","year":"2018","unstructured":"Wang, L. M. et al. Nr4a1 plays a crucial modulatory role in Th1\/Th17 cell responses and CNS autoimmunity. Brain Behav. Immun. 68, 44\u201355 (2018).","journal-title":"Brain Behav. Immun."},{"key":"66509_CR53","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.immuni.2015.11.008","volume":"43","author":"LK Mackay","year":"2015","unstructured":"Mackay, L. K. et al. T-box transcription factors combine with the cytokines TGF-\u03b2 and IL-15 to control tissue-resident memory T cell fate. Immunity 43, 1101\u20131111 (2015).","journal-title":"Immunity"},{"key":"66509_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam6346","volume":"2","author":"BT Malik","year":"2017","unstructured":"Malik, B. T. et al. Resident memory T cells in the skin mediate durable immunity to melanoma. Sci. Immunol. 2, eaam6346 (2017).","journal-title":"Sci. Immunol."},{"key":"66509_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1386362","volume":"7","author":"H L\u00e4ubli","year":"2018","unstructured":"L\u00e4ubli, H. et al. The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitors. Oncoimmunology 7, e1386362 (2018).","journal-title":"Oncoimmunology"},{"key":"66509_CR56","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1084\/jem.20190738","volume":"216","author":"A Tokunaga","year":"2019","unstructured":"Tokunaga, A. et al. Selective inhibition of low-affinity memory CD8(+) T cells by corticosteroids. J. Exp. Med. 216, 2701\u20132713 (2019).","journal-title":"J. Exp. Med."},{"key":"66509_CR57","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/imm.13176","volume":"160","author":"X Chi","year":"2020","unstructured":"Chi, X., Li, Y. & Qiu, X. V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation. Immunology 160, 233\u2013247 (2020).","journal-title":"Immunology"},{"key":"66509_CR58","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nri3216","volume":"12","author":"Z Xu","year":"2012","unstructured":"Xu, Z., Zan, H., Pone, E. J., Mai, T. & Casali, P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat. Rev. Immunol. 12, 517\u2013531 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"66509_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s43657-023-00140-y","volume":"4","author":"C Zhao","year":"2024","unstructured":"Zhao, C. et al. Synergistically augmenting cancer immunotherapy by physical manipulation of pyroptosis induction. Phenomics 4, 298\u2013312 (2024).","journal-title":"Phenomics"},{"key":"66509_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong, X. et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J. Hematol. Oncol. 15, 174 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"66509_CR61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee, D. W. et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124, 188\u2013195 (2014).","journal-title":"Blood"},{"key":"66509_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26642","volume":"64","author":"SJ Rotz","year":"2017","unstructured":"Rotz, S. J. et al. Severe cytokine release syndrome in a patient receiving PD-1-directed therapy. Pediatr. Blood Cancer 64, e26642 (2017).","journal-title":"Pediatr. Blood Cancer"},{"key":"66509_CR63","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ccell.2023.03.014","volume":"41","author":"C Sievers","year":"2023","unstructured":"Sievers, C. et al. Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer. Cancer cell 41, 887\u2013902.e885 (2023).","journal-title":"Cancer cell"},{"key":"66509_CR64","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jtho.2021.03.016","volume":"16","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Efficacy and safety of first-line immunotherapy combinations for advanced NSCLC: a systematic review and network meta-analysis. J. Thorac. Oncol. 16, 1099\u20131117 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"66509_CR65","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jtho.2023.07.017","volume":"18","author":"S Dacic","year":"2023","unstructured":"Dacic, S. et al. International Association for the Study of Lung Cancer Study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy. J. Thorac. Oncol. 18, 1290\u20131302 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"66509_CR66","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","volume":"19","author":"R Rami-Porta","year":"2024","unstructured":"Rami-Porta, R. et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J. Thorac. Oncol. 19, 1007\u20131027 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"66509_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.6004\/jnccn.2019.0013","volume":"17","author":"JA Thompson","year":"2019","unstructured":"Thompson, J. A. et al. Management of immunotherapy-related toxicities, version 1. 2019. J. Natl. Compr. Canc Netw. 17, 255\u2013289 (2019).","journal-title":"2019. J. Natl. Compr. Canc Netw."},{"key":"66509_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","volume":"5","author":"I Puzanov","year":"2017","unstructured":"Puzanov, I. et al. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. J. Immunother. Cancer 5, 95 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"66509_CR69","doi-asserted-by":"publisher","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","volume":"28","author":"J Haanen","year":"2017","unstructured":"Haanen, J. et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 28, iv119\u2013iv142 (2017).","journal-title":"Ann. Oncol."},{"key":"66509_CR70","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","volume":"36","author":"JR Brahmer","year":"2018","unstructured":"Brahmer, J. R. et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline. J. Clin. Oncol. 36, 1714\u20131768 (2018).","journal-title":"J. Clin. Oncol."},{"key":"66509_CR71","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"66509_CR72","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e4 (2019).","journal-title":"Cell Syst."},{"key":"66509_CR73","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"66509_CR74","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"66509_CR75","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"66509_CR76","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"66509_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res 9, 47 (2020).","journal-title":"F1000Res"},{"key":"66509_CR78","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv, https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"66509_CR79","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","volume":"12","author":"D Hao","year":"2022","unstructured":"Hao, D. et al. The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma. Cancer Discov. 12, 2626\u20132645 (2022).","journal-title":"Cancer Discov."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66509-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T14:02:21Z","timestamp":1767103341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66509"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66509-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11645"}}